🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/02/1997 | 46,34 | 46,46 | 44,61 | 44,79 | -3,59% | 3,99% | 5.881.795 |
| 26/02/1997 | 46,22 | 46,70 | 45,09 | 46,46 | -0,38% | 3,48% | 7.383.579 |
| 25/02/1997 | 46,93 | 46,93 | 45,80 | 46,64 | -0,64% | 2,41% | 6.810.533 |
| 24/02/1997 | 45,15 | 47,05 | 45,15 | 46,93 | +3,42% | 4,23% | 5.534.488 |
| 21/02/1997 | 46,10 | 46,22 | 45,15 | 45,38 | -1,42% | 2,33% | 8.116.970 |
| 20/02/1997 | 46,76 | 46,93 | 45,86 | 46,04 | -1,53% | 2,30% | 6.116.128 |
| 19/02/1997 | 47,11 | 47,53 | 46,40 | 46,76 | -1,26% | 2,41% | 5.229.939 |
| 18/02/1997 | 46,46 | 47,59 | 46,40 | 47,35 | +1,93% | 2,57% | 7.383.370 |
| 14/02/1997 | 46,99 | 47,35 | 46,34 | 46,46 | -2,26% | 2,16% | 8.403.074 |
| 13/02/1997 | 45,80 | 47,65 | 45,80 | 47,53 | +3,91% | 4,04% | 8.343.338 |
| 12/02/1997 | 44,37 | 45,74 | 44,31 | 45,74 | +3,09% | 3,23% | 7.465.323 |
| 11/02/1997 | 44,19 | 44,37 | 43,65 | 44,37 | +0,68% | 1,62% | 4.075.882 |
| 10/02/1997 | 44,61 | 44,73 | 44,01 | 44,07 | -1,20% | 1,60% | 4.239.998 |
| 07/02/1997 | 44,13 | 44,61 | 43,77 | 44,61 | +1,63% | 1,89% | 4.826.250 |
| 06/02/1997 | 42,76 | 43,95 | 42,58 | 43,89 | +2,36% | 3,21% | 5.679.322 |
| 05/02/1997 | 44,01 | 44,07 | 42,46 | 42,88 | -1,91% | 3,66% | 4.227.213 |
| 04/02/1997 | 43,12 | 43,71 | 42,88 | 43,71 | +1,52% | 1,94% | 4.399.294 |
| 03/02/1997 | 43,36 | 43,54 | 42,88 | 43,06 | -0,41% | 1,51% | 4.274.163 |
| 31/01/1997 | 43,42 | 44,19 | 43,24 | 43,24 | +0,28% | 2,20% | 7.578.088 |
| 30/01/1997 | 42,58 | 43,18 | 42,34 | 43,12 | +2,41% | 1,96% | 6.203.112 |
| 29/01/1997 | 41,45 | 42,16 | 41,39 | 42,10 | +1,44% | 1,87% | 6.085.107 |
| 28/01/1997 | 41,15 | 41,87 | 40,91 | 41,51 | +2,96% | 2,32% | 6.289.048 |
| 27/01/1997 | 40,79 | 41,33 | 40,31 | 40,31 | -1,31% | 2,49% | 3.794.179 |
| 24/01/1997 | 41,21 | 41,81 | 40,79 | 40,85 | -0,72% | 2,46% | 6.127.027 |
| 23/01/1997 | 42,40 | 43,06 | 41,09 | 41,15 | -2,40% | 4,64% | 7.387.142 |
| 22/01/1997 | 41,51 | 42,28 | 41,39 | 42,16 | +2,17% | 2,16% | 5.070.434 |
| 21/01/1997 | 40,49 | 41,51 | 40,43 | 41,27 | +1,02% | 2,65% | 5.223.022 |
| 20/01/1997 | 40,85 | 41,15 | 40,37 | 40,85 | -0,44% | 1,90% | 5.259.493 |
| 17/01/1997 | 40,49 | 41,63 | 40,43 | 41,03 | +1,47% | 2,95% | 7.394.478 |
| 16/01/1997 | 39,84 | 40,73 | 39,66 | 40,43 | +1,80% | 2,69% | 6.318.392 |